The company provided the updated long-term target ahead of its investor day. “We are proud of the strong and resilient foundation we have built that enables us to deliver compelling future growth,” said Jason Hollar, Chief Executive Officer of Cardinal Health (CAH). “We look forward to highlighting the significant opportunities in front of Cardinal Health as we continue to evolve to reach our full potential.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health CEO: Our industry has been resilient, stronger than usual
- Cardinal Health to hold an investor day
- Cardinal Health’s Strong Execution and Industry Tailwinds Support Buy Rating with Potential for Double-Digit EPS Growth
- Cardinal Health price target raised to $170 from $165 at BofA
- Citius Oncology enters distribution services agreement with Cardinal Health